The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor
Open accessAbstract
The Brn-3a POU family transcription factor has been shown to strongly activate expression of the Bcl-2 proto-oncogene and thereby protect neuronal cells from programmed cell death (apoptosis). This activation of the Bcl-2 promoter by Brn-3a is strongly inhibited by the p53 anti-oncogene protein. This inhibitory effect of p53 on Brn-3a-mediated transactivation is observed with nonoverlapping gene fragments containing either the Bcl-2 p1 or p2 promoters but is not observed with other Brn-3a-activated promoters such as in the gene encoding alpha-internexin or with an isolated Brn-3a binding site from the Bcl-2 promoter linked to a heterologous promoter. In contrast, p53 mutants, which are incapable of binding to DNA, do not affect Brn-3a-mediated activation of the Bcl-2 p1 and p2 promoters. Moreover, Brn-3a and p53 have been shown to bind to adjacent sites in the p2 promoter and to directly interact with one another, both in vitro and in vivo, with this interaction being mediated by the POU domain of Brn-3a and the DNA binding domain of p53. The significance of these effects is discussed in terms of the antagonistic effects of Bcl-2 and p53 on the rate of apoptosis and the overexpression of Brn-3a in specific tumor cell types.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional BCL-2 family members reported as p53 targets include BCL2190, 191 and BID192—but these are not directly regulated by p53 according to meta-analysis data18 (Supplementary Table S2).”
From Census and evaluation of p53 target genes (2017) · cites this paper as [190]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Bcl-2 and the regulation of programmed cell death
Reed, J. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.1.1 · Cited by 2,287
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Miyashita, T., Krajewski, S., Krajewska, M., Wang, H., Lin, H., Liebermann, D. A., Hoffman‐Liebermann, B., & Reed, J. C. (1994) · PubMed · Cited by 2,143
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Involvement of the bcl -2 Gene in Human Follicular Lymphoma
Tsujimoto, Y., Cossman, J., Jaffe, E. S., & Croce, C. M. (1985) · Science · doi:10.1126/science.3874430 · Cited by 1,787
Luckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,650
Identification of a p53-dependent negative response element in the bcl-2 gene.
Miyashita, T., Harigai, M., Hanada, M., & Reed, J. C. (1994) · PubMed · Cited by 746
Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., & Stark, G. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.1 · Cited by 725
Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.
Nissim, A., Hoogenboom, H. R., Tomlinson, I. M., Flynn, G., Midgley, C., Lane, D. P., & Winter, G. P. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06308.x · Cited by 575
Self-citation
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Research works printed but not linked: 11
- Chiou, 1994, Mol. Cell. Biol., 14, 2556
- Marcellus, 1996, Cell Growth Differ., 7, 1643
- Lee, 1996, Anticancer Res., 16, 3007
- Miyashita, 1994, Oncogene, 9, 1799
- Miyashita, 1994, Cancer Res., 54, 3131
- Morris, 1994, Mol. Cell. Biol., 14, 6907
- Baniahmad, 1995, Mol. Endocrinol., 9, 34
- Park, 1994, Oncogene, 9, 1899
- Leblond-Francillard, 1997, J. Clin. Endocrinol. Metab., 82, 89
- Latchman, 1997, Int. J. Oncol., 10, 1133
- Reed, 1991, Cancer Res., 51, 6529
Cited by
Sorted by citations
Items 101–143 of 143
Rodríguez, R. P., Fuentes, M. P., Oliván, A. M., Martínez‐Palacián, A., Roncero, C., González, M. P., & Oset‐Gasque, M. J. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21342 · Cited by 13
Mijatović, S., Maksimović‐Ivanić, D., Timotijević, G. S., Miljković, D. M., Donia, M., Libra, M., Coco, M., McCubrey, J. A., Al‐Abed, Y., & Korać, A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.026 · Cited by 12
Chiarugi, V. P., Rosso, M. D., & Magnelli, L. (2002) · Molecular Biotechnology · doi:10.1385/mb:22:2:123 · Cited by 12
Berwick, D. C., Diss, J. K. J., Budhram-Mahadeo, V. S., & Latchman, D. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071456 · Cited by 11
Self-citationBudhram-Mahadeo, V. S., Morris, P., Ndisang, D., Irshad, S., Lozano, G., Pedley, B. R., & Latchman, D. S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00813-3 · Cited by 11
Self-citationGα12/13 Basally Regulates p53 through Mdm4 Expression
Kim, M.-S., Lee, S. M., Kim, W., Ki, S. H., Moon, A., Lee, C. H., & Kim, S. G. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0395 · Cited by 10
Ye, Z., Peng, H., Fang, Y., Feng, J., & Yang, D. (2007) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-007-0012-3 · Cited by 10
Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription
Hudson, C. D., Sayan, E., Melino, G., Knight, R. A., Latchman, D. S., & Budhram-Mahadeo, V. S. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.45 · Cited by 10
Self-citationBrn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer
Jung, S., Kang, Y. E., Lee, G. H., Liu, L., Oh, C., Jin, Y., Lim, M. A., Lee, K., Oh, T., Won, H.-R., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa316 · Cited by 9
The POU domain transcription factor Brn-3a protects cortical neurons from apoptosis
Smith, M. D. P., Ensor, E. A., Kinloch, R. A., & Latchman, D. S. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00008 · Cited by 9
Self-citationGene expression of the POU factor Brn-3a is regulated by two different promoters
Fraß, B. K., Vaßen, L., & Möröy, T. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00540-7 · Cited by 9
Gao, H., Liu, X., Tian, K., Meng, Y., Yu, C., & Peng, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1060271 · Cited by 8
RetractedHigh Throughput Assays for Analyzing Transcription Factors
Li, X., Jiang, X., & Yaoi, T. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.333 · Cited by 8
Kajihara, A., Takahashi, A., Ohnishi, K., Imai, Y., Yamakawa, N., Yasumoto, J.-I., Ohnishi, T., & Kirita, T. (2008) · International Journal of Hyperthermia · doi:10.1080/02656730802348339 · Cited by 7
Dependence of p53-deficient cells on the DHX9 DExH-box helicase
Lee, T., & Pelletier, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15889 · Cited by 6
McKinney, K. M., & Prives, C. L. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_2 · Cited by 6
Immunohistochemical Expression of p53 and Bcl-2 in Algerian Cervical Carcinoma
Khalissa, D., Khenchouche, A., Xie, X., Li, Y., Ouhida, S., & Mahnane, A. (2018) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1348 · Cited by 5
Unaltered expression of Bcl-2 and TAG-1/axonin-1 precedes sensory apoptosis in Brn3a knockout mice
Eng, S., Kozlov, S. V., & Turner, E. E. (2003) · Neuroreport · doi:10.1097/00001756-200302100-00002 · Cited by 5
Fu, C., Shi, X., Gong, Y., Wan, Y., Sun, Z., Shi, H., Wang, Z., Marinaccio, C., Crispino, J. D., & Xu, K. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495092 · Cited by 4
Functional interaction between Brn-3a and Src-1 co-activates Brn-3a-mediated transactivation
Dennis, J. H., Budhram-Mahadeo, V. S., & Latchman, D. S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00500-4 · Cited by 3
Self-citationMatthews, E. R., Abodunrin, R. O., Hurley, J. D., Paul, S., Gutiérrez, J. A., Bogar, A. R., & Ward, M. C. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011900 · Cited by 2
Lee, H., Haque, S., Gupta, R., Kolitz, J. E., Allen, S. L., Rai, K., Chiorazzi, N., & Mongini, P. K. A. (2024) · Lymphatics · doi:10.3390/lymphatics2020005 · Cited by 2
Expression of survivin and p53 genes in patients with alopecia areata: A case–control study
Marie, R. E. M., El‐Fadeal, N. M. A., & Atef, L. M. (2020) · Australasian Journal of Dermatology · doi:10.1111/ajd.13433 · Cited by 2
Expression of Developmentally Regulated Transcription Factors in Merkel Cell Carcinoma
Leonard, J. H., Cook, A. L., Gele, M. V., Speleman, F., & Sturm, R. A. (2003) · Springer eBooks · doi:10.1007/978-3-662-10358-6_30 · Cited by 2
ESF1 positively regulates MDM2 and promotes tumorigenesis
Zhang, P., Sun, C., Yin, T., Guo, J., Chong, D., Tang, Y., Liu, Y., Li, Y., Gu, Y., & Lü, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133652 · Cited by 1
Prakash, A., Patel, Y., & Roy, J. K. (2025) · Genes & Genomics · doi:10.1007/s13258-025-01620-3 · Cited by 1
Transcriptional Repression by the p53 Tumor Suppressor Protein
Zilfou, J. T., & Murphy, M. E. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5_4 · Cited by 1
DNA damage response genes and chromosome 11q21-q24 candidate tumor suppressor genes in breast cancer
Allinen, M. (2002) · Cited by 1
Criswell, T. L., & Boothman, D. A. (2003) · doi:10.21236/ada418107
Role of transcription factors in sensory neuron specification
Montelius, A. (2007) · Figshare
Modulation of p53's transcriptional function by small molecules
Nikulenkov, F. (2011) · Figshare
Enge, M. (2009) · Figshare
Three BRN s are better than two
Goding, C. R. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12150
정진혁, 이준영, 이선미, 최태부, & 안성관 (2009) · KSBB Journal
Regulation des POU Faktors Brn-3a und Analyse seiner Effektorgene
Fraß, B. K. (2001) · DuEPublico (University of Duisburg-Essen)
Modeling p53 transcriptional regulation
Riley, T. (2008) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t31836rn
Teresa, S. G. M., Alberto, M. M. I., Luis, T. G. J., Antonio, P. C. M., Ramiro, S. L., Raul, M. V., Jose, V. O. V., Rocio, O. L., & Augusto, R. M. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-17-3726
An investigation into the occurrence of nonlinear attractor in cellular dynamics
He, C. (2018) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/75939
Maskell, L. J. (2019) · UCL Discovery (University College London)
Haupt, Y., & Haupt, S. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726233981.793539121
Niu, Q., Niu, L., Kariuki, J., Fan, D., Bai, R., Li, J., Lee, H., Fleming, P., (14951413), S. S. R., Ivanov, A. A., et al. (2026) · ASPET Discovery · doi:10.1016/j.aspetd.2026.100027
Metadata
- Authors
- Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S.
- Affiliations
- University College London (GB)
- University of Dundee (GB)
- Stanford Medicine (US)
- Corresponding author
- Latchman, David S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 274
- Issue
- 21
- Pages
- 15237-15244
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2131045322
- Cited by
- 144
- References
- 40
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 2 · 2015: 2 · 2014: 6 · 2013: 10 · 2012: 2
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- p53, Brn3a, POU transcription factors, Bcl-2, Bcl-2 promoter, transcriptional repression, protein-protein interaction, POU domain, DNA-binding domain, apoptosis, neuronal survival, alpha-internexin
- MeSH terms
- Cells, Cultured, DNA-Binding Proteins, Promoter Regions, Genetic, Transcription Factors, Genes, p53, Genes, bcl-2, Transcription Factor Brn-3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review